Pomerantz Law Firm Investigates Abeona Therapeutics for Potential Securities Fraud
The law firm of Pomerantz LLP is investigating potential securities fraud or other unlawful business practices by Abeona Therapeutics Inc. (NASDAQ: ABEO) and certain officers or directors, on behalf of investors. The investigation was prompted after Abeona disclosed in a press release that only four out of five treatments with its one-time therapy ZEVASKYN were recognized for revenue due to insufficient product batches. Following this news, Abeona's stock price dropped 14.95%, or $1.12 per share, closing at $6.35 on August 13, 2026. Pomerantz LLP is a well-known firm in corporate and securities litigation with a long history of recovering damages for class members affected by financial misconduct.
Tickers: $ABEO